WO2022169051A1 - Composition antibactérienne et antivirale exempte de métaux lourds et film la contenant - Google Patents
Composition antibactérienne et antivirale exempte de métaux lourds et film la contenant Download PDFInfo
- Publication number
- WO2022169051A1 WO2022169051A1 PCT/KR2021/010320 KR2021010320W WO2022169051A1 WO 2022169051 A1 WO2022169051 A1 WO 2022169051A1 KR 2021010320 W KR2021010320 W KR 2021010320W WO 2022169051 A1 WO2022169051 A1 WO 2022169051A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- weight
- film
- antibacterial
- parts
- antiviral
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title claims abstract description 70
- 230000000840 anti-viral effect Effects 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims description 58
- 239000002313 adhesive film Substances 0.000 claims abstract description 14
- 229910001385 heavy metal Inorganic materials 0.000 claims abstract description 5
- 238000000034 method Methods 0.000 claims abstract 4
- 239000012790 adhesive layer Substances 0.000 claims description 32
- 239000004925 Acrylic resin Substances 0.000 claims description 25
- 229920005749 polyurethane resin Polymers 0.000 claims description 22
- 239000010410 layer Substances 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- PTBDIHRZYDMNKB-UHFFFAOYSA-N 2,2-Bis(hydroxymethyl)propionic acid Chemical compound OCC(C)(CO)C(O)=O PTBDIHRZYDMNKB-UHFFFAOYSA-N 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- 229920000139 polyethylene terephthalate Polymers 0.000 claims description 9
- 239000005020 polyethylene terephthalate Substances 0.000 claims description 9
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 claims description 7
- 239000007921 spray Substances 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 229910004298 SiO 2 Inorganic materials 0.000 claims description 6
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 230000001678 irradiating effect Effects 0.000 claims description 6
- 229920001451 polypropylene glycol Polymers 0.000 claims description 6
- 229910018072 Al 2 O 3 Inorganic materials 0.000 claims description 5
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 claims description 5
- -1 Polyethylene Terephthalate Polymers 0.000 claims description 5
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 239000011247 coating layer Substances 0.000 claims description 3
- 125000005442 diisocyanate group Chemical group 0.000 claims description 3
- 239000000839 emulsion Substances 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000010030 laminating Methods 0.000 claims description 2
- 230000007774 longterm Effects 0.000 abstract description 3
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000011248 coating agent Substances 0.000 description 24
- 230000000052 comparative effect Effects 0.000 description 23
- 241000700605 Viruses Species 0.000 description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000000853 adhesive Substances 0.000 description 12
- 230000001070 adhesive effect Effects 0.000 description 12
- 229920002799 BoPET Polymers 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 238000000576 coating method Methods 0.000 description 10
- 238000001723 curing Methods 0.000 description 10
- 238000002360 preparation method Methods 0.000 description 9
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 8
- 238000003848 UV Light-Curing Methods 0.000 description 8
- 239000010949 copper Substances 0.000 description 8
- IATRAKWUXMZMIY-UHFFFAOYSA-N strontium oxide Chemical compound [O-2].[Sr+2] IATRAKWUXMZMIY-UHFFFAOYSA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 7
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 7
- 229910052802 copper Inorganic materials 0.000 description 7
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 7
- 229910052709 silver Inorganic materials 0.000 description 7
- 239000004332 silver Substances 0.000 description 7
- DTLIXPLJFCRLJY-UHFFFAOYSA-N 1-(1-aminocyclooctyl)cyclooctan-1-amine Chemical compound C1CCCCCCC1(N)C1(N)CCCCCCC1 DTLIXPLJFCRLJY-UHFFFAOYSA-N 0.000 description 6
- 241000282414 Homo sapiens Species 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000011575 calcium Substances 0.000 description 6
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 6
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 6
- 229920005862 polyol Polymers 0.000 description 6
- 150000003077 polyols Chemical class 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000008199 coating composition Substances 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 5
- 239000012948 isocyanate Substances 0.000 description 5
- 150000002513 isocyanates Chemical class 0.000 description 5
- 239000004417 polycarbonate Substances 0.000 description 5
- 229920000515 polycarbonate Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 238000002834 transmittance Methods 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 4
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 4
- 239000000292 calcium oxide Substances 0.000 description 4
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 4
- 239000003999 initiator Substances 0.000 description 4
- 239000000395 magnesium oxide Substances 0.000 description 4
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 4
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000004926 polymethyl methacrylate Substances 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 230000007261 regionalization Effects 0.000 description 3
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 description 3
- ARXJGSRGQADJSQ-UHFFFAOYSA-N 1-methoxypropan-2-ol Chemical compound COCC(C)O ARXJGSRGQADJSQ-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- 208000025721 COVID-19 Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 241000186245 Corynebacterium xerosis Species 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 241000709661 Enterovirus Species 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000007888 film coating Substances 0.000 description 2
- 238000009501 film coating Methods 0.000 description 2
- XXMIOPMDWAUFGU-UHFFFAOYSA-N hexane-1,6-diol Chemical compound OCCCCCCO XXMIOPMDWAUFGU-UHFFFAOYSA-N 0.000 description 2
- 238000007602 hot air drying Methods 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- QWQFVUQPHUKAMY-UHFFFAOYSA-N 1,2-diphenyl-2-propoxyethanone Chemical compound C=1C=CC=CC=1C(OCCC)C(=O)C1=CC=CC=C1 QWQFVUQPHUKAMY-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- KWVGIHKZDCUPEU-UHFFFAOYSA-N 2,2-dimethoxy-2-phenylacetophenone Chemical compound C=1C=CC=CC=1C(OC)(OC)C(=O)C1=CC=CC=C1 KWVGIHKZDCUPEU-UHFFFAOYSA-N 0.000 description 1
- ZQWQIRVELCNHIR-UHFFFAOYSA-N 2-(2-hydroxyethoxy)ethyl 2-phenylacetate Chemical compound OCCOCCOC(=O)CC1=CC=CC=C1 ZQWQIRVELCNHIR-UHFFFAOYSA-N 0.000 description 1
- KMNCBSZOIQAUFX-UHFFFAOYSA-N 2-ethoxy-1,2-diphenylethanone Chemical compound C=1C=CC=CC=1C(OCC)C(=O)C1=CC=CC=C1 KMNCBSZOIQAUFX-UHFFFAOYSA-N 0.000 description 1
- LWRBVKNFOYUCNP-UHFFFAOYSA-N 2-methyl-1-(4-methylsulfanylphenyl)-2-morpholin-4-ylpropan-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)C(C)(C)N1CCOCC1 LWRBVKNFOYUCNP-UHFFFAOYSA-N 0.000 description 1
- UGVRJVHOJNYEHR-UHFFFAOYSA-N 4-chlorobenzophenone Chemical compound C1=CC(Cl)=CC=C1C(=O)C1=CC=CC=C1 UGVRJVHOJNYEHR-UHFFFAOYSA-N 0.000 description 1
- 241000122229 Acinetobacter johnsonii Species 0.000 description 1
- 241001678559 COVID-19 virus Species 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000222178 Candida tropicalis Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241001517050 Corynebacterium accolens Species 0.000 description 1
- 241000158508 Corynebacterium amycolatum Species 0.000 description 1
- 241000709687 Coxsackievirus Species 0.000 description 1
- 201000003075 Crimean-Congo hemorrhagic fever Diseases 0.000 description 1
- 241000701022 Cytomegalovirus Species 0.000 description 1
- 241000725619 Dengue virus Species 0.000 description 1
- 241001115402 Ebolavirus Species 0.000 description 1
- 241000991587 Enterovirus C Species 0.000 description 1
- 241001333951 Escherichia coli O157 Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000190708 Guanarito mammarenavirus Species 0.000 description 1
- 241000893570 Hendra henipavirus Species 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- 241000724675 Hepatitis E virus Species 0.000 description 1
- 241000709715 Hepatovirus Species 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 244000309467 Human Coronavirus Species 0.000 description 1
- 241000725303 Human immunodeficiency virus Species 0.000 description 1
- 241000342334 Human metapneumovirus Species 0.000 description 1
- 241000701806 Human papillomavirus Species 0.000 description 1
- 241000484121 Human parvovirus Species 0.000 description 1
- 241000712431 Influenza A virus Species 0.000 description 1
- 241000710842 Japanese encephalitis virus Species 0.000 description 1
- 241000712890 Junin mammarenavirus Species 0.000 description 1
- 241000712902 Lassa mammarenavirus Species 0.000 description 1
- 241000711828 Lyssavirus Species 0.000 description 1
- 241000712898 Machupo mammarenavirus Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241001115401 Marburgvirus Species 0.000 description 1
- 241000712079 Measles morbillivirus Species 0.000 description 1
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 1
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 241000700559 Molluscipoxvirus Species 0.000 description 1
- 241000711386 Mumps virus Species 0.000 description 1
- 241000186365 Mycobacterium fortuitum Species 0.000 description 1
- 241000526636 Nipah henipavirus Species 0.000 description 1
- 241001263478 Norovirus Species 0.000 description 1
- 241000710944 O'nyong-nyong virus Species 0.000 description 1
- 241000150452 Orthohantavirus Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 241000700639 Parapoxvirus Species 0.000 description 1
- 201000000239 Phlebotomus fever Diseases 0.000 description 1
- 241001505332 Polyomavirus sp. Species 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000711798 Rabies lyssavirus Species 0.000 description 1
- 241000702670 Rotavirus Species 0.000 description 1
- 241000710799 Rubella virus Species 0.000 description 1
- 241000315672 SARS coronavirus Species 0.000 description 1
- 241000192617 Sabia mammarenavirus Species 0.000 description 1
- 241000369757 Sapovirus Species 0.000 description 1
- 241000150288 Sin Nombre orthohantavirus Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241001147698 Staphylococcus cohnii Species 0.000 description 1
- 241000191984 Staphylococcus haemolyticus Species 0.000 description 1
- 241000192087 Staphylococcus hominis Species 0.000 description 1
- 241001147691 Staphylococcus saprophyticus Species 0.000 description 1
- 241000191978 Staphylococcus simulans Species 0.000 description 1
- 241000192086 Staphylococcus warneri Species 0.000 description 1
- 241000191973 Staphylococcus xylosus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 208000000389 T-cell leukemia Diseases 0.000 description 1
- 208000028530 T-cell lymphoblastic leukemia/lymphoma Diseases 0.000 description 1
- 241000700618 Vaccinia virus Species 0.000 description 1
- 241000701067 Varicellovirus Species 0.000 description 1
- 241000700647 Variola virus Species 0.000 description 1
- 241000710886 West Nile virus Species 0.000 description 1
- 241000710772 Yellow fever virus Species 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 244000309743 astrovirus Species 0.000 description 1
- ZCILODAAHLISPY-UHFFFAOYSA-N biphenyl ether Natural products C1=C(CC=C)C(O)=CC(OC=2C(=CC(CC=C)=CC=2)O)=C1 ZCILODAAHLISPY-UHFFFAOYSA-N 0.000 description 1
- ZNAAXKXXDQLJIX-UHFFFAOYSA-N bis(2-cyclohexyl-3-hydroxyphenyl)methanone Chemical compound C1CCCCC1C=1C(O)=CC=CC=1C(=O)C1=CC=CC(O)=C1C1CCCCC1 ZNAAXKXXDQLJIX-UHFFFAOYSA-N 0.000 description 1
- ZLSMCQSGRWNEGX-UHFFFAOYSA-N bis(4-aminophenyl)methanone Chemical compound C1=CC(N)=CC=C1C(=O)C1=CC=C(N)C=C1 ZLSMCQSGRWNEGX-UHFFFAOYSA-N 0.000 description 1
- RFVHVYKVRGKLNK-UHFFFAOYSA-N bis(4-methoxyphenyl)methanone Chemical compound C1=CC(OC)=CC=C1C(=O)C1=CC=C(OC)C=C1 RFVHVYKVRGKLNK-UHFFFAOYSA-N 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 229910052810 boron oxide Inorganic materials 0.000 description 1
- 229910052793 cadmium Inorganic materials 0.000 description 1
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 description 1
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical class C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- UHESRSKEBRADOO-UHFFFAOYSA-N ethyl carbamate;prop-2-enoic acid Chemical compound OC(=O)C=C.CCOC(N)=O UHESRSKEBRADOO-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- ZYMKZMDQUPCXRP-UHFFFAOYSA-N fluoro prop-2-enoate Chemical compound FOC(=O)C=C ZYMKZMDQUPCXRP-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 238000007756 gravure coating Methods 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000002672 hepatitis B Diseases 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- FSPSELPMWGWDRY-UHFFFAOYSA-N m-Methylacetophenone Chemical compound CC(=O)C1=CC=CC(C)=C1 FSPSELPMWGWDRY-UHFFFAOYSA-N 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- YQUQWHNMBPIWGK-UHFFFAOYSA-N p-isopropyl-phenol Natural products CC(C)C1=CC=C(O)C=C1 YQUQWHNMBPIWGK-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229960003424 phenylacetic acid Drugs 0.000 description 1
- 239000003279 phenylacetic acid Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 229940037649 staphylococcus haemolyticus Drugs 0.000 description 1
- 229940037648 staphylococcus simulans Drugs 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
- 241001529453 unidentified herpesvirus Species 0.000 description 1
- 229940051021 yellow-fever virus Drugs 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/20—Adhesives in the form of films or foils characterised by their carriers
- C09J7/201—Adhesives in the form of films or foils characterised by their carriers characterised by the release coating composition on the carrier layer
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J7/00—Chemical treatment or coating of shaped articles made of macromolecular substances
- C08J7/04—Coating
- C08J7/06—Coating with compositions not containing macromolecular substances
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L33/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- C08L33/04—Homopolymers or copolymers of esters
- C08L33/06—Homopolymers or copolymers of esters of esters containing only carbon, hydrogen and oxygen, which oxygen atoms are present only as part of the carboxyl radical
- C08L33/10—Homopolymers or copolymers of methacrylic acid esters
- C08L33/12—Homopolymers or copolymers of methyl methacrylate
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D1/00—Coating compositions, e.g. paints, varnishes or lacquers, based on inorganic substances
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09D—COATING COMPOSITIONS, e.g. PAINTS, VARNISHES OR LACQUERS; FILLING PASTES; CHEMICAL PAINT OR INK REMOVERS; INKS; CORRECTING FLUIDS; WOODSTAINS; PASTES OR SOLIDS FOR COLOURING OR PRINTING; USE OF MATERIALS THEREFOR
- C09D5/00—Coating compositions, e.g. paints, varnishes or lacquers, characterised by their physical nature or the effects produced; Filling pastes
- C09D5/14—Paints containing biocides, e.g. fungicides, insecticides or pesticides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J11/00—Features of adhesives not provided for in group C09J9/00, e.g. additives
- C09J11/08—Macromolecular additives
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J175/00—Adhesives based on polyureas or polyurethanes; Adhesives based on derivatives of such polymers
- C09J175/04—Polyurethanes
- C09J175/08—Polyurethanes from polyethers
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/20—Adhesives in the form of films or foils characterised by their carriers
- C09J7/22—Plastics; Metallised plastics
- C09J7/25—Plastics; Metallised plastics based on macromolecular compounds obtained otherwise than by reactions involving only carbon-to-carbon unsaturated bonds
- C09J7/255—Polyesters
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09J—ADHESIVES; NON-MECHANICAL ASPECTS OF ADHESIVE PROCESSES IN GENERAL; ADHESIVE PROCESSES NOT PROVIDED FOR ELSEWHERE; USE OF MATERIALS AS ADHESIVES
- C09J7/00—Adhesives in the form of films or foils
- C09J7/30—Adhesives in the form of films or foils characterised by the adhesive composition
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2367/00—Characterised by the use of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Derivatives of such polymers
- C08J2367/02—Polyesters derived from dicarboxylic acids and dihydroxy compounds
Definitions
- the present invention relates to a composition capable of producing an antibacterial and antiviral film that can be attached to the front and rear parts of a mobile phone. It relates to a coating composition for producing an adhesive film.
- the antibacterial film market is growing rapidly, and with the advent of COVID-19, it is spreading throughout everyday life and industry at a very rapid pace.
- the antibacterial film is attached to almost any object or space that comes into contact with the human body in daily life.
- the generally distributed film has copper or silver as its main component.
- the commonly used films containing copper or silver have only been reported to have antibacterial properties against common pathogens for 24 hours, and there is no report on whether they can achieve antibacterial or antiviral effects within a shorter time than that.
- transparent plastic materials such as PET (polyethyleneterephthalate), PC (polycarbonate), and PMMA (poly-methylmethacrylate) are widely used as the material of the film.
- PET polyethyleneterephthalate
- PC polycarbonate
- PMMA poly-methylmethacrylate
- One object of the present invention relates to an antibacterial and antiviral composition suitable for application to a film because it has excellent antibacterial and antiviral properties and can achieve both transparency and durability after coating.
- an aspect of the present invention is a film layer coated on one side of the antibacterial and antiviral composition comprising a hydroxyapatite (Hydroxyapatite); And it provides an antibacterial and antiviral film having an adhesive layer formed on the other side of the film layer.
- a hydroxyapatite Hydroapatite
- Another aspect provides a method for producing the antibacterial and antiviral adhesive film.
- One aspect provides an antibacterial and antiviral composition comprising hydroxyapatite.
- Hydroxyapatite is a chemical formula Ca 10 (PO 4 ) 6 (OH) 2 It is a mineral form of calcium apatite in its natural state. Hydroxyapatite reacts with water to form hydroxyl radicals, thereby destroying cell membranes of viruses or bacteria, denaturing proteins, and destroying genes, thereby producing an antibacterial effect.
- the antibacterial and antiviral composition may be for film coating.
- the composition can be further processed into powder, solution, suspension, solid of various three-dimensional shape, etc. without using as a coating agent, but is particularly suitable for use in coating a film.
- the film may be manufactured for attachment of a specific product, and the product includes, for example, a mobile phone, a handle, a button, a dining table, wallpaper, a floor, and the like, but is not limited thereto.
- the film may be selected from the group consisting of polyethyleneterephthalate (PET), polycarbonate (PC), and poly-methylmethacrylate (PMMA).
- PET polyethyleneterephthalate
- PC polycarbonate
- PMMA poly-methylmethacrylate
- the film may be a PET film, in which case it may be more advantageous because it is stronger and not crushed or torn.
- the antibacterial and antiviral film may be attached to one side, specifically, the front and rear parts of the mobile phone.
- the antibacterial and antiviral composition may include Ca(OH) 2 , CaCO 3 , SiO 2 , and P 2 O 5 .
- the hydroxyapatite may be formed by Ca(OH) 2 and P 2 O 5 .
- Ca(OH) 2 and P 2 O 5 in the antimicrobial composition may be essential to achieve an antibacterial or antiviral effect, and SiO 2 and CaCO 3 may be essential to maintain a certain degree of hardness and transparency even after the antimicrobial composition is coated.
- the composition may include 85 to 95 parts by weight of Ca(OH) 2 , 3 to 8 parts by weight of CaCO 3 , 0.5 to 1.5 parts by weight of SiO 2 , and 0.1 to 0.3 parts by weight of P 2 O 5 . If it is out of the range of parts by weight, antibacterial and antiviral effects of up to 99% cannot be achieved within 1 minute, and hardness or transparency may decrease, which may affect quality.
- the antibacterial and antiviral composition may further include SO 3 , CaO, Al 2 O 3 , Fe 2 O 3 , SrO, MgO, and B 2 O 3 .
- the composition of the present invention does not use heavy metals, so it is harmless to the human body and has a long-lasting antibacterial activity.
- additional sulfur, aluminum, iron, strontium, magnesium and boron compounds were added, both antibacterial and antiviral properties and longevity could be achieved within a harmless range to the human body. did. Moreover, these materials do not affect the hardness and transparency of the coating.
- the composition is more specifically, 0.3 to 0.5 SO 3 , 0.3 to 0.5 CaO, 0.3 to 0.5 Al 2 O 3 , 0.25 to 0.45 Fe 2 O 3 , 0.1 to 0.3 SrO, 0.05 to 0.2 MgO, and 0.05 to 0.2 of B 2 O 3 . If it is out of the above range, the antibacterial and antiviral properties or durability may be reduced, or the hardness or transparency of the film may be deteriorated.
- the present invention relates to a film coated with an antibacterial and antiviral composition suitable for attachment to one side of a mobile phone. To do this, it must have transparency that does not affect the appearance of the mobile phone, and it must have appropriate hardness to withstand frequent external shocks. In addition, as it is one of the household items that come into contact with the hand the most, one of the parts most exposed to bacteria and viruses in the human body, it should be able to inactivate bacteria and viruses in a short time. To achieve all these conditions, the composition and composition ratio of the coating composition may be very important.
- the composition may be one capable of killing 99% or more of bacteria and viruses within 1 minute. This effect is about 1000 times or more, more specifically, more than 1400 times superior to the conventional silver or copper-containing film.
- the bacteria are Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Candida tropicalis, Malesezia pachydermatis, Salmonella typhimurium.
- Salmonella typhimurium Salmonella typhimurium
- Acinetobacter johnsonii Corynebacterium accolens, Corynebacterium amycolatum, Corynebacterium xerosis, Corynebacterium xerosis Nebacterium jeikeium, Staphylococcus aureus, Staphylococcus haemolyticus, Staphylococcus warneri, Staphylococcus Staphylococcus saprophyticus, Staphylococcus cohnii, Staphylococcus hominis, Staphylococcus xylosus, Staphylococcus simul It may be at least one selected from the group consisting of Lance (Staphylococcus simulans), Mycobacterium fortuitum, and Micrococcus luteus.
- the virus is rhinovirus, poliovirus, rotavirus, norovirus, enterovirus, hepatovirus, astrovirus, sapovirus, hepatitis E virus, influenza A/B/C virus, parainfluenza virus, mum Mumps virus, measles virus, human metapneumovirus, RS virus, Nipah virus, Hendra virus, yellow fever virus, dengue virus, Japanese encephalitis virus, West Nile virus, hepatitis B/C virus, eastern and western hemp encephalitis Virus, o'nyong-nyong virus, rubella virus, Lassa virus, junin virus, Machupo virus, guanarito virus, sabia virus, Crimea Congo Hemorrhagic fever virus, Sandfly fever, Hantavirus, Sin Nombre virus, rabies virus, Ebola virus, Marburgvirus, bat lyssavirus, human T-cell leukemia virus, human Immunodeficiency virus, human coronavirus, S
- the bacteria may be selected from the group consisting of E. coli, E. coli O-157, and Staphylococcus aureus
- the virus may be selected from the group consisting of COVID-19, influenza A virus, and coxsackie virus. may be selected.
- the antibacterial and antiviral composition does not contain heavy metals.
- the composition does not contain any heavy metals such as cadmium, mercury, and chromium, and does not contain polybrominated biphenyl compounds (PBBs) or polybrominated biphenyl ether compounds (PBPEs).
- PBBs polybrominated biphenyl compounds
- PBPEs polybrominated biphenyl ether compounds
- the composition may not contain zinc, silver, and copper. Zinc, silver, and copper are components commonly used in commercially available antibacterial films, but in the present invention, it was confirmed that these components have lower antibacterial effects compared to the coating composition of the present invention, and these components are rather the coating composition of the present invention may interfere with the effectiveness of “Does not include” the component may mean that the detection amount is 2 ppm or less.
- the antibacterial and antiviral composition according to one embodiment is coated on one side of the film layer; And it provides an antibacterial and antiviral film having an adhesive layer formed on the other side of the film layer.
- the coating layer formed of the antibacterial and antiviral composition may further include an ultraviolet curing coating agent.
- Another aspect is mixing the antibacterial and antiviral composition and the UV curing coating agent according to an embodiment; coating the mixture on a film; And it provides a method for producing a film coated with an antibacterial and antiviral composition comprising the step of curing the mixture by irradiating ultraviolet rays.
- the solvent may be an organic solvent.
- the organic solvent is ketones, acetates, phenyls, glycol ethers or alcohols, for example, toluene, methyl isobutyl ketone, ethyl acetate, propylene glycol methyl ether, methanol, acetone, chloroform, or a combination thereof. can be, but is not limited thereto.
- UV curing coating agent refers to a coating agent that is cured when irradiated with UV light, and as an initiator, oxy-phenyl-acetic acid 2-[2 oxo-2 phenyl-acetoxy-ethoxy]-ethyl ester, oxy- including phenyl-acetic acid 2-[2-hydroxy-ethoxy]-ethyl ester or 2-methyl-1-[4-(methylthio)phenyl]-2-(4-morpholinyl)-1-propanone can, but is not limited to.
- the UV curing coating agent may include, for example, a urethane acrylate oligomer as an oligomer that can be cured with the initiator, and may further include an acrylate monomer, fluoroacrylate, silicone acrylate, etc. to aid curing.
- oligomers are successfully cured even when mixed with the antibacterial and antiviral composition according to one embodiment to achieve sufficient transparency and hardness, and are suitable for forming sufficient pores so that antibacterial and antiviral properties can be expressed.
- the amount of oligomers in the UV-curable coating agent is 30 to 45 wt% based on the total amount of the coating agent, and the curing aid is preferably 2 to 5 wt% or less, respectively.
- the coating step may be coating with micro-gravure coating.
- This coating method can be coated by evenly distributing the antibacterial and antiviral composition on the film, and contributes to increasing the production rate.
- the step of irradiating the ultraviolet rays may further include drying with hot air. Since the UV curing coating agent is added with a monomer to aid in curing, and a solvent is used to facilitate mixing, impurities and solvents can be removed through hot air drying. However, it is preferable that the hot air does not exceed 50°C. There is a condition for applying hot air in the adhesive layer forming step, and if the severe condition continues, the antibacterial and antiviral effect may be lost.
- composition for film coating of the present invention is suitable for producing an antibacterial and antiviral film because it does not affect the curing reaction.
- an adhesive film further comprising an adhesive layer on the other side of the film layer coated with the antibacterial and antiviral composition.
- the adhesive layer can prevent stains left on the place where the film is attached using polyurethane or damage the product, can be strongly attached without additional adhesive components including polyacrylic polymer, and has good transparency.
- the adhesive layer specifically includes a polyurethane resin and a polyacrylate resin in a weight ratio of 4:1
- the polyurethane resin is a polyol polyethylene-polypropylene glycol and diisocyanate, specifically, toluene diisocyanate 1:2 of
- the polyacrylate resin may include methyl methacrylate and butyl acrylate in a molar ratio of 4:1
- the polyethylene-polypropylene glycol may be composed of ethylene glycol and propylene glycol in a molar ratio of 2:1.
- the molar ratio of each monomer constituting the polyurethane resin and the polyacrylate resin may be important for proper transparency and adhesion.
- the polyol may preferably have a number average molecular weight of 500 to 2000, specifically 800 to 1200.
- the polyurethane resin is made of a polymer of polyol and isocyanate, and in this case, it contributes to maintaining long-term stability and can form an adhesive layer even at a relatively low temperature of 50° C. or less.
- a small amount of diaminobicyclooctane (DABCO) may be added to promote polymerization, for example, 0.01 to 0.1 parts by weight based on 100 parts by weight of the total polymer of the polyol and the isocyanate.
- Another aspect is a first mixing step of mixing a polyurethane resin, a polyacrylate resin, a crosslinking agent, and a photoinitiator; adding and mixing dimethylol propionic acid and hexanediol to the first mixture, then adding water dropwise to emulsify; forming an adhesive layer by spraying and heating the emulsion with a fine spray on the back surface of the film layer coated with the antibacterial and antiviral composition; and laminating a PET (Polyethylene Terephthalate) film on the adhesive layer and curing the adhesive layer by irradiating ultraviolet rays; It provides a method for producing an adhesive film comprising a.
- the back side means the opposite side of the layer coated by spraying the antibacterial and antiviral composition from the film.
- the laminated PET film may serve as a release layer.
- the crosslinking agent is a polyurethane resin and a polyacrylate resin to be firmly mixed and fixed, and an isocyanate-based crosslinking agent may be preferable.
- the crosslinking agent may be added in an amount of 0.1 to 1 parts by weight, specifically 0.5 parts by weight, based on 100 parts by weight of the total of the polyurethane resin and the polyacrylate resin.
- the photoinitiator is for curing the adhesive layer, and is 1-hydroxycyclohexylphenyl ketone, 2,2-dimethoxy-2-phenyl-acetophenone, xanthone, benzaldehyde, anthraquinone, 3-methylacetophenone, 4-chloro Benzophenone, 4,4'-dimethoxybenzophenone, 4,4'-diaminobenzophenone, benzoin propyl ether, benzoinethyl ether, 1-(4-isopropyl-phenol)-2-hydroxy-2 -methyl propan-1-one, thioxanthone, and the like, but is not limited thereto.
- the photoinitiator may be added in an amount of 0.1 to 1 parts by weight, specifically 0.3 parts by weight, based on 100 parts by weight of the total of the polyurethane resin and the polyacrylate resin.
- the dimethylol propionic acid and hexanediol may be added in an amount of 0.1 to 1 parts by weight of dimethylol propionic acid and 0.1 to 0.5 parts by weight of hexanediol based on 100 parts by weight of the polyurethane resin and the polyacrylate resin.
- water is added dropwise and mixed rapidly to cause emulsification, which helps the composition to be suitable for fine spray application.
- the emulsion is used to form an adhesive layer by spraying a fine spray on the film layer.
- the step of forming the adhesive layer may be spraying for 3 to 5 minutes while applying hot air of about 45 to 50°C. By spraying while applying hot air, the drying time can be shortened to 3 to 5 minutes even at a relatively low temperature of 50° C. or less. It is preferable that the temperature does not exceed 50° C., and it is preferable that the temperature does not exceed 5 minutes.
- the amount of fine spray injection can be increased or decreased depending on the required thickness of the adhesive layer, but the adhesive layer thickness may be 100 ⁇ m or less, specifically 1 ⁇ m to 50 ⁇ m, so that the adhesive layer can be well formed within the same temperature and drying time as described above.
- a polymerization inhibitor such as hydroquinone may be added based on 100 parts by weight of the total reactant to stop the polymerization.
- the polyacrylate resin may preferably have a number average molecular weight of 700,000 to 900,00, more specifically, 750,000 to 800,000.
- the number average molecular weight of the polyacrylate resin is important for maintaining the long-term stability of the adhesive layer and for forming the adhesive layer at a relatively low temperature of 50° C. or less.
- Each polymer component and weight ratio included in the adhesive layer is important to avoid harsh conditions when forming the adhesive layer on the antibacterial and antiviral film to maintain the antibacterial or antiviral effect.
- various products can be UV-cured to coat the antibacterial and antiviral film.
- the film coated with the antibacterial and antiviral composition it can be easily attached to a mobile phone, handle, button, restaurant table, wallpaper, floor, etc. to achieve antibacterial and antiviral effect of 90% or more within 1 minute.
- the film prepared using the antibacterial and antiviral composition of the present invention can exhibit semi-permanent and immediate antibacterial and antiviral effects without additional treatment by attaching it to the front and rear portions of the mobile phone.
- the composition for antibacterial coating to be used for the antibacterial film was prepared in the same composition as in Table 1 (Example 1) below. Specifically, a UV curing coating agent using toluene as a solvent was prepared, and the coating composition of Example 1 was mixed thereto. Then, the mixed solution was micro-gravure coated on a PET film, and dried with hot air at 50° C. while irradiating ultraviolet rays to cure the coating material on the PET film. When the PET antibacterial film prepared above was used for attachment, an adhesive layer was formed by further processing and curing the urethane adhesive.
- Example 1 (content, weight ratio) Ca(OH) 2 (Calcium hydroxide) 91.00 CaCO 3 (Calcium carbonate) 5.60 SiO 2 (Silicon dioxide) 1.00 SO 3 (sulfur trioxide) 0.41 CaO (Calcium oxide) 0.39 Al 2 O 3 (Aluminum oxide) 0.35 Fe 2 O 3 (Iron oxide) 0.34 SrO (strontium oxide) 0.20 P 2 O 5 (Phosphoric acid) 0.20 MgO (Magnesium oxide) 0.11 B 2 O 3 (Boron oxide) 0.11
- the antibacterial effect of the present invention was evaluated in comparison with commercially available films.
- E.Coli 400 ⁇ l of E.Coli prepared at a concentration of 1x10 6 CFU/mL was applied to commercially available silver-containing films, copper-containing films, PET films coated with Example 1, and uncoated PET films, respectively, It was left at room temperature for 30 minutes. Then, each film was scraped off with a sterilized cotton swab, the cotton swab was immersed in the medium, and the medium was again applied to the solid medium at 10 -1 and 10 -2 concentrations. Then, the colony growth was observed by incubation at 37° C. for 24 hours, and the number is shown in Table 2 and FIG. 1 below.
- Example 1 As a result, all bacteria in contact with the film coated in Example 1 were killed and no colonies were observed.
- polyethylene-polypropylene glycol prepared in a ratio of 2:1 with ethylene glycol and propylene glycol was prepared, and 2 moles of toluene diisocyanate and 1 mole of the polyethylene-polypropylene glycol (number average molecular weight 1000) were added to a round bottom flask. 100 g was added, 10 mg of diaminobicyclooctane (DABCO) was added and mixed, and stirred at a reaction temperature of 70° C. for 2 hours to prepare a polyurethane resin.
- DABCO diaminobicyclooctane
- a polyacrylate resin was prepared and prepared. Specifically, 100 g of a mixture of methyl methacrylate and butyl acrylate in a molar ratio of 4:1 was added to 120 g of ethyl acetate at a reaction temperature of 70° C. under a nitrogen atmosphere, and azobisisobutyronitrile, a reaction initiator, was added while maintaining the temperature. (AIBN) 0.5 g was added and reacted for 10 hours to prepare a polyacrylate resin (number average molecular weight 800,000).
- AIBN azobisisobutyronitrile
- a polyurethane resin was prepared by adding and mixing 1 mmol of diaminobicyclooctane (DABCO) to 3 moles of toluene diisocyanate without a polyol, followed by stirring at a reaction temperature of 70° C. for 2 hours. The following steps were performed in the same manner as in Example 2 to prepare an adhesive composition.
- DABCO diaminobicyclooctane
- Adhesive films were prepared in the same manner as above using the adhesive compositions of Comparative Examples 1 to 4.
- Comparative Examples 3 and 4 had remarkably low adhesive strength, because the adhesive layer was not properly formed.
- the adhesive film In order to evaluate the durability of the adhesive film, it is attached to a polycarbonate transparent board using a 2kg roller, and left for 30 days in a space of about 60°C with a humidity of 90RH% for 30 days to observe changes in appearance such as peeling, bubble formation, and pattern formation. observed.
- Example 2 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Durability change no change bubble formation Edge peeling, bubble formation Edge peeling, wavy pattern formation wave pattern formation
- Example 2 As a result of observation, no change was observed in Example 2, whereas in Comparative Example 1, a large number of small bubbles were generated, in Comparative Example 2, peeling was observed from the corner, and Comparative Examples 3 and 4 were in a specific part when pressed. The formation of wavy patterns was observed.
- Transparency is measured by calculating light transmittance according to ASTM D1003 standard measurement method using a haze transmittance meter (NDH-2000N) after peeling the PET film layer from each adhesive film prepared in Preparation Example 3 and attaching it to a 2 mm transparent glass. The transmittance was measured and evaluated.
- Example 2 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 light transmittance 93.54 89.01 84.32 90.53 91.23
- Example 2 As a result, in the case of Example 2, the transmittance was remarkably excellent and the transparency was evaluated as good, and Comparative Examples 1 to 4 all had low transparency, but Comparative Example 2 was found to have particularly low transparency.
Abstract
La présente invention concerne un film antibactérien et antiviral et, plus spécifiquement, un film adhésif antibactérien et antiviral et son procédé de préparation, le film ne contenant pas de métaux lourds et étant ainsi sans danger tout en présentant une transparence, une dureté et une stabilité à long terme améliorées.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2021-0017601 | 2021-02-08 | ||
KR1020210017601A KR102258923B1 (ko) | 2021-02-08 | 2021-02-08 | 중금속 무함유의 항균 및 항바이러스 조성물 및 이를 포함하는 필름 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022169051A1 true WO2022169051A1 (fr) | 2022-08-11 |
Family
ID=76150001
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2021/010320 WO2022169051A1 (fr) | 2021-02-08 | 2021-08-05 | Composition antibactérienne et antivirale exempte de métaux lourds et film la contenant |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR102258923B1 (fr) |
WO (1) | WO2022169051A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102258923B1 (ko) * | 2021-02-08 | 2021-05-31 | 박진희 | 중금속 무함유의 항균 및 항바이러스 조성물 및 이를 포함하는 필름 |
KR102371552B1 (ko) | 2021-10-25 | 2022-03-08 | 주식회사 코이코리아 | 제형안정성을 높인 항균 및 항바이러스성 조성물의 제조방법 및 그를 이용한 항균 및 항바이러스성 조성물 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060094134A (ko) * | 2005-02-23 | 2006-08-29 | 조광페인트주식회사 | 수분산성 자외선 경화형 폴리우레탄 아크릴레이트수지의 제조방법 및 그 도료 조성물 |
JP2009520076A (ja) * | 2005-12-14 | 2009-05-21 | スリーエム イノベイティブ プロパティズ カンパニー | 抗菌接着フィルム |
KR101069642B1 (ko) * | 2011-02-16 | 2011-10-04 | 이학철 | 휴대용 단말기의 디스플레이 보호필름 |
KR20160032305A (ko) * | 2014-09-15 | 2016-03-24 | (주)엘지하우시스 | 첨가제용 내오염성 아크릴계 수지 |
KR20200138295A (ko) * | 2018-03-30 | 2020-12-09 | 가부시키가이샤 아데카 | 입상 자외선 흡수제 및 수지 조성물 |
KR102258923B1 (ko) * | 2021-02-08 | 2021-05-31 | 박진희 | 중금속 무함유의 항균 및 항바이러스 조성물 및 이를 포함하는 필름 |
-
2021
- 2021-02-08 KR KR1020210017601A patent/KR102258923B1/ko active IP Right Grant
- 2021-08-05 WO PCT/KR2021/010320 patent/WO2022169051A1/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060094134A (ko) * | 2005-02-23 | 2006-08-29 | 조광페인트주식회사 | 수분산성 자외선 경화형 폴리우레탄 아크릴레이트수지의 제조방법 및 그 도료 조성물 |
JP2009520076A (ja) * | 2005-12-14 | 2009-05-21 | スリーエム イノベイティブ プロパティズ カンパニー | 抗菌接着フィルム |
KR101069642B1 (ko) * | 2011-02-16 | 2011-10-04 | 이학철 | 휴대용 단말기의 디스플레이 보호필름 |
KR20160032305A (ko) * | 2014-09-15 | 2016-03-24 | (주)엘지하우시스 | 첨가제용 내오염성 아크릴계 수지 |
KR20200138295A (ko) * | 2018-03-30 | 2020-12-09 | 가부시키가이샤 아데카 | 입상 자외선 흡수제 및 수지 조성물 |
KR102258923B1 (ko) * | 2021-02-08 | 2021-05-31 | 박진희 | 중금속 무함유의 항균 및 항바이러스 조성물 및 이를 포함하는 필름 |
Also Published As
Publication number | Publication date |
---|---|
KR102258923B1 (ko) | 2021-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2022169051A1 (fr) | Composition antibactérienne et antivirale exempte de métaux lourds et film la contenant | |
US20120202912A1 (en) | Surface treatment by photopolymerisation to obtain biocidal properties | |
JP6817963B2 (ja) | 相乗効果を示す抗菌性材料 | |
ES2356305T3 (es) | Recubrimiento antimicrobiano curable por radiación. | |
RU2448990C2 (ru) | Анионный латекс в качестве носителя для биоактивных ингредиентов и способы его изготовления и применения | |
MX2007001203A (es) | Composiciones de plata antimicrobianas. | |
CN101253182B (zh) | 抗微生物双胍金属配合物 | |
JP2015131821A (ja) | 抗菌性ビグアニド金属錯体 | |
CN107236143A (zh) | 阳离子‑两性离子共聚物涂层及其制备方法和应用 | |
EP2346955B1 (fr) | Compositions aqueuses antitaches pour revêtement | |
JP6781256B2 (ja) | 抗菌組成物、抗菌膜、抗菌膜付き基材、抗菌膜の製造方法、及び、抗菌膜付き基材の製造方法 | |
Liu et al. | Antimicrobial property of halogenated catechols | |
CN101925651A (zh) | 亲水组合物和具有防霉性能的亲水元件 | |
CN106163802B (zh) | 带抗菌层的基材、抗菌片、放射线摄影装置、触控面板 | |
KR100546820B1 (ko) | 나노 실버 입자를 함유한 전착 도료 조성물 및 이의사용방법 | |
JP7277930B2 (ja) | フェナレン-1-オン含有光増感剤組成物、フェナレン-1-オン化合物およびその使用 | |
KR20100127791A (ko) | 친수성 부재, 핀재, 알루미늄제 핀재, 열교환기 및 에어컨 | |
KR102262892B1 (ko) | 항바이러스, 항균, 항곰팡이 및 이지클리닝 특성을 갖는 친환경 수성 도료 조성물 | |
WO2022245157A1 (fr) | Peinture ou composition de revêtement soluble dans l'eau ayant une capacité antibactérienne, désodorisante et de durabilité | |
CN115044237A (zh) | 涂料组合物及其制备方法和涂层 | |
CA2384427A1 (fr) | Copolymeres de composes acryloylaminoalkyl | |
JP3506470B2 (ja) | 抗菌性能を有する間仕切用化粧材 | |
CN110922831A (zh) | 一种医用防雾防溅套头式面罩的制备方法 | |
JP2021054769A (ja) | 抗ウィルス性部材、抗ウィルス性部材の製造方法及び抗ウィルス組成物 | |
US6596064B2 (en) | Biocidal-antifouling agents with low ecotoxicity index |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21924949 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21924949 Country of ref document: EP Kind code of ref document: A1 |